companydata.dkcompanydata.dk

Roche Pharmaceuticals A/S: Financial statements 2014

CVR: 25230515

Source: annual report 2014, Danish Business Authority

01/01/2014 – 31/12/2014

Roche Pharmaceuticals A/S (CVR 25230515) has filed annual accounts for 2014. In 2014, the company reported revenue of DKK 839,936,000 and a net result of DKK 26,654,000 compared with DKK 14,505,000 the year before. That is an increase of 21.8% compared with the year before. The profit margin was 3.2%. Equity in the 2014 report amounted to DKK 100,227,000. The solvency ratio was 30.1%. The company had 103 employees in the financial year.

Revenue
DKK 839,936,000
Gross Profit
DKK 144,300,000
Profit/Loss
DKK 26,654,000
Equity
DKK 100,227,000
Total Assets
DKK 333,052,000
Employees
103

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2014839.9 mio.144.3 mio.26.7 mio.100.2 mio.103
2013689.8 mio.128.9 mio.14.5 mio.88.6 mio.103

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2014

Roche Pharmaceuticals A/S: The 2013 annual report is outMay 30, 2014

Roche Pharmaceuticals A/S has published its annual report for 2013. Revenue came to DKK 689,754,000, and the net result was DKK 14,505,000.

Roche Pharmaceuticals A/S appoints new auditorMay 6, 2014

As of May 6, 2014, KPMG P/S has been appointed auditor of Roche Pharmaceuticals A/S.

Auditor steps down at Roche Pharmaceuticals A/SMay 6, 2014

As of May 6, 2014, EY Godkendt Revisionspartnerselskab has stepped down as auditor of Roche Pharmaceuticals A/S.

Ronald Jeyung Park joins the board of Roche Pharmaceuticals A/SMay 6, 2014

As of May 6, 2014, Ronald Jeyung Park has joined the board of directors of Roche Pharmaceuticals A/S.

Ronald Jeyung Park joins Roche Pharmaceuticals A/S as directorMay 6, 2014

As of May 6, 2014, Ronald Jeyung Park is registered as director of Roche Pharmaceuticals A/S.

Luc Jozef Leon Dirckx steps down as director of Roche Pharmaceuticals A/SMay 6, 2014

As of May 6, 2014, Luc Jozef Leon Dirckx has stepped down as director of Roche Pharmaceuticals A/S.

Janet Friedman Makepeace leaves the board of Roche Pharmaceuticals A/SApr 1, 2014

As of April 1, 2014, Janet Friedman Makepeace has left the board of directors of Roche Pharmaceuticals A/S.

Luc Jozef Leon Dirckx joins Roche Pharmaceuticals A/S as directorApr 1, 2014

As of April 1, 2014, Luc Jozef Leon Dirckx is registered as director of Roche Pharmaceuticals A/S.

Janet Friedman Makepeace steps down as director of Roche Pharmaceuticals A/SApr 1, 2014

As of April 1, 2014, Janet Friedman Makepeace has stepped down as director of Roche Pharmaceuticals A/S.

Beat Christoph Krähenmann joins the board of Roche Pharmaceuticals A/SMar 17, 2014

As of March 17, 2014, Beat Christoph Krähenmann has joined the board of directors of Roche Pharmaceuticals A/S.

About Roche Pharmaceuticals A/S

Roche Pharmaceuticals A/S is a Danish company of the type Aktieselskab based in København V, founded in 1970. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named ROCHE A/S. MEDICINALVARER & KEMIKALIER. The management consists of Carole Hassoun. The board consists of Isabel Marianne Joerin (chair), Carole Hassoun and Ehab Abdelmoneim Youssef Hassan. The company is owned by Roche Holding AG. The company has 96 employees (2026). In 2025, the company reported revenue of DKK 928,824,000 and a net result of DKK 31,319,000 compared with DKK 24,277,000 the year before. Equity in the 2025 report amounted to DKK 195,179,000.

Source: annual report 2025, Danish Business Authority